Exploration of the weight neutral effects of insulin detemir compared to insulin glargine: A measure of satiety and calories consumed in type 1 diabetes.
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 04 Oct 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.